Our mission
To curate knowledge to advance the world's most promising biomedical innovations
The most advanced data curation in biopharma
Biorelate was founded in 2014 from cutting-edge scientific research into how biomedical curation can utilise existing dark knowledge to accelerate future drug discovery. Staying true to our roots, we have always believed that a better understanding of today’s science can bring forward the next generation of life-saving therapeutics being developed by world-leading researchers.
As the incredible progress of scientific researchers continues to compound the huge volume of growing and evolving biomedical data, Biorelate’s mission has never been so important. Through our platform, Galactic AI™, we use artificial intelligence-led curation to provide and enable the insights that matter to scientists and organisations developing the innovations of the future.
Our Values
At Biorelate, our values define our behaviour in everything we do as a company.
We embrace change as we know this shapes our future. We are insightful, always exploring new possibilities and actively seeking new ideas.
We take ownership in everything we do, we take pride in our output and delivery and celebrate success.
We are open-minded, flexible and responsive in our approach, always willing to adapt to deliver excellence.
We understand each other's worth and abilities and continually support and challenge one another to achieve greatness. We are one team, working toward the same goal.
We show integrity and are transparent and respectful of everyone. We communicate openly and honestly to solve a problem.
Our board and advisors
CEO & Founder, Biorelate
Chair, Biorelate
Life Science Partner, Catapult Ventures Group
Senior Investment Manager, Maven Capital Partners
Portfolio Director, YFM Equity Partners
Meet the leadership team.
Over 80 years of experience
Our History
2014
Company founded. Manchester University PhD spinout after success working with Pfizer.
2017
Completed >10 contracts for customers that include biotechs & pharmaceutical companies.
2018
Raised investment with Catapult Ventures, Maven & angel investors
2020
Galactic AI™ official product launch, following early adopter success.
2022
Raised further investment from YFM, Maven, Triplepoint and other investors.
Would you like to join our mission?
We’re always on the lookout for talented software developers, bioinformaticians and industry professionals in full-time and internship positions.
Explore Galactic AI™
Request a demo or contact us to see Galactic AI™ in action, and discover how it provides data scientists and computational biologists with unmatched cause-and-effect evidence in biopharma.